Muscular Dystrophy

>

The NeurologyLive® Muscular Dystrophy Disease Spotlight page offers specific coverage on the latest expert conversations and clinical trial data associated with the treatment and management of patients with muscular dystrophies.

Latest News

Susan Matesanz, MD  (Credit: Children's Hospital of Philadelphia)
Gaps in Follow Up and Sustained Clinical Care Observed in Pediatric Muscular Dystrophy

July 16th 2024

A recent study revealed that pediatric patients with Duchenne and Becker muscular dystrophy have low rates of corticosteroid use.

Early Sustained Improvements in Oculopharyngeal Muscular Dystrophy Seen Through BB-301
Early Sustained Improvements in Oculopharyngeal Muscular Dystrophy Seen Through BB-301

July 16th 2024

Capricor to Meet With FDA Following Positive 3-Year Data on Duchenne Agent CAP-1002
Capricor to Meet With FDA Following Positive 3-Year Data on Duchenne Agent CAP-1002

July 9th 2024

Strength Training Provides Several Noted Benefits to Women With Myotonic Dystrophy Type 1
Strength Training Provides Several Noted Benefits to Women With Myotonic Dystrophy Type 1

July 2nd 2024

Phase 1/2 AFFINITY DUCHENNE Trial Expands to Include Younger Cohort of Duchenne Muscular Dystrophy
Phase 1/2 AFFINITY DUCHENNE Trial Expands to Include Younger Cohort of Duchenne Muscular Dystrophy

July 1st 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.